$BIO breaking out of the downtrend as the market starts paying attention to the DeSci + peptide meta.

still a low mcap, so ppl are basically buying it as exposure to a basket of early biotech bets at a discount, with all the mess that comes with it.

if the meta really plays out, $BIO could send hard since there’s no second tier yet.

but peptides feel kinda tricky for normies to wrap their head around.

got some micro caps below if you wanna dig, most are super early and still very much in the pump dump game.